GE Healthcare To Market India-Developed Portable Heart Monitor
This article was originally published in PharmAsia News
GE Healthcare's seven-pound MAC 800 heart monitor, which it expects to market in the United States, was the result not of U.S. technology, but of engineers in China and India. The company has been expanding its engineering staff in those countries for just over a decade. Indian engineers developed the MAC 800's forerunner as part of an effort to make a portable diagnostic that Indian physicians could carry into rural villages. The result was a device only a fifth of the size of existing monitors, and is to be marketed in the U.S. by GE for $2,500. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.